Safety and FDA regulations for musculoskeletal allografts: Perspective of an orthopaedic surgeon

Clinical Orthopaedics and Related Research

Volumn 435, Issue , 2005, Pages 22-30

  Joyce, Michael J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE ALLOGRAFT; CONFERENCE PAPER; FOOD AND DRUG ADMINISTRATION; HEALTH CARE FACILITY; HUMAN; INFORMED CONSENT; PRIORITY JOURNAL; RECIPIENT; SAFETY; UNITED KINGDOM;

EID: 20444387182     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000165849.32661.5e     Document Type: Conference Paper

References (23)

1. CBER: A Proposed Approach to Regulation of Cellular and Tissue-Based Products. February 28, 1997, FDA Publication. Available at www.fda.gov/cber/ tiss.htm. Accessed on
2. CBER: Guidance for Industry: Availability of Licensed Donor Screening Tests Labeled for use with Cadaveric Blood Specimens. June 23, 2000, FDA Publication. Available at www.fda. gov/cber/tiss.htm. Accessed on
3. CBER: Guidance for Industry (draft): Eligibility Determination for Donors of Human Cells, Tissues, and Tissue Based Products (HCT/Ps). May 24, 2004, FDA Publication. Available at www.fda. gov/cber/tiss.htm. Accessed on
4. CBER: Guidance for Industry: Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and variant Creutzfeldt-Jakob Disease (vCJD) by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). June 14, 2002. FDA Publication. Available at www.fda.gov/cber/tiss. htm. Accessed on
5. CBER: Guidance for Industry: Screening and Testing of Human Tissue Intended for Transplantation. July 29, 1997, FDA Publication. Available at www.fda.gov/cber/tiss.htm. Accessed on
6. CBER: Guidance for Industry: Validation of Procedures for Processing of Human Tissues Intended for Transplantation. March 8, 2002, FDA Publication. Available at www.fda.gov/cber/tiss.htm. Accessed on
7. CDC: Hepatitis C Virus Transmission from an Antibody-Negative Organ and Tissue Donor-United States, 2000-2002. Morb Mortal Wkly Rep 52:273-276, 2003.
8. CDC: Invasive Streptococcus Pyrogenes after Allograft Implantation: Colorado 2003. Morb Mortal Wkly Rep 52:1173-1176, 2003.
9. CDC: Update: Allograft-Associated Bacterial Infections: United States 2002. Morb Mortal Wkly Rep 51:207-210, 2002.
10. CDC: Update: Unexplained Deaths Following Knee Surgery: Minnesota 2001. Morb Mortal Wkly Rep 50:1080-1083, 2001.
11. Current Good Tissue Practice for Manufacturers of Human Cellular and Tissue-Based Products: Inspection and Enforcement: Proposed Rule. 66 Fed Reg:1508-1559, 2001.
12. Current Good Tissue Practice for Human Cell, Tissue, and Cellular and Tissue-Based Product Establishments; Inspection and Enforcement: Final Rule 21 CFR Parts 16, 1270 and 1271 (D,E,F) 69 Fed Reg:16-611-68688, November 24, 2004.
13. Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products: Final Rule 21 CFR Parts 210, 211, 820 and 1271. 69 Fed Reg:29786-29834 May 25, 2004.
14. Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue-Based Products: Proposed Rule. 63 Fed Reg:26744-26755, 1998.
15. Human Cells, Tissues, and Cellular and Tissue-Based Products: Establishment Registration and Listing. Final Rule 21 CFR Parts 207, 807, 1271. 66 Fed Reg:5447-5469, 2001.
16. Human Tissue Intended for Transplantation: Interim Rule 21 CFR Parts 16, 1270. 58 Fed Reg:65514, 1993.
17. Human Tissue Intended for Transplantation: Final Rule 21 CFR Parts 16, 1270. 62 Fed Reg:40429-40447, 1997.
18. Simonds RJ, Holmberg SD, Hurwitz RL, et al: Transmission of human immunodeficiency virus type 1 from a seronegative organ tissue donor. N Engl J Med 326:726-732, 1992.
19. Stamer SL, Glynn SA, Kleinman SH, et al: Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 351:760-768, 2004.
20. Suitability Determination for Donors of Human Cellular and Tissue-Based Products: Proposed Rule. 64 Fed Reg:52696-52723, 1999.
21. Veen MR, Bloem MD, Petit PLC: Sensitivity and negative predictive value of swab-cultures in musculoskeletal allograft procurement. Clin Orthop 300:259-263, 1994.
22. Vehmeyer SBW, Bloem RM, Deijkers RLM, Veen MR, Petit PLC: A comparative study of blood and bone marrow cultures in cadaveric bone donation. J Hosp Inf 43:305-308, 1999.
23. Zou S, Dodd RY, Stramer SL, Strong DM: Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med 351:751-752, 2004.